K
Keiji Fukuda
Researcher at Li Ka Shing Faculty of Medicine, University of Hong Kong
Publications - 99
Citations - 29021
Keiji Fukuda is an academic researcher from Li Ka Shing Faculty of Medicine, University of Hong Kong. The author has contributed to research in topics: Influenza A virus subtype H5N1 & Influenza A virus. The author has an hindex of 46, co-authored 95 publications receiving 27831 citations. Previous affiliations of Keiji Fukuda include United States Department of Agriculture & University of Hong Kong.
Papers
More filters
Journal ArticleDOI
An economic analysis of annual influenza vaccination of children.
TL;DR: The number of high-risk children that receive influenza vaccine should be maximized to achieve improved health outcomes as well as cost savings.
Journal ArticleDOI
Lack of Evidence for Human-to-Human Transmission of Avian Influenza A (H9N2) Viruses in Hong Kong, China 1999
Timothy M. Uyeki,Yu Hoi Chong,Jacqueline M. Katz,Wilina Lim,Yuk Yin Ho,Sophia S. Wang,Thomas Tsang,Winnie Wan Yee Au,Shuk Chi Chan,Thomas Rowe,Jean Hu-Primmer,Jensa C. Bell,William W. Thompson,Carolyn B. Bridges,Nancy J. Cox,Kwok Hang Mak,Keiji Fukuda +16 more
TL;DR: In this paper, the authors conducted four retrospective cohort studies of persons exposed to these two H9N2 patients to assess whether human-to-human transmission of avian H 9N2 viruses had occurred.
Lack of Evidence for Human-to- Human Transmission of Avian Influenza A (H9N2) Viruses in
Timothy M. Uyeki,Yu-Hoi Chong,Jacqueline M. Katz,Wilina Lim,Yuk-Yin Ho,Sophia S. Wang,Winnie Wan-Yee,Shuk-Chi Chan,Jean Hu-Primmer,Jensa C. Bell,William W. Thompson,Nancy J. Cox,Kwok-Hang Mak,Keiji Fukuda +13 more
TL;DR: No serologic evidence of H9N2 infection was found in family members or health-care workers who had close contact with the H 9N2-infected children, suggesting that these H9n2 viruses were not easily transmitted from person to person.
Journal ArticleDOI
A global pandemic influenza vaccine action plan
Marie Paule Kieny,Alejandro Costa,Joachim Hombach,Peter Carrasco,Yuri Pervikov,David Salisbury,Michel Gréco,Ian D. Gust,Marc LaForce,Carlos Franco-Paredes,Jose Ignacio Santos,Eric D'Hondt,Guus F. Rimmelzwaan,Ruth A. Karron,Keiji Fukuda +14 more
TL;DR: A consultation of all stakeholders in influenza vaccines and immunization in Geneva in 2006 resulted in a global action plan outlining promising specific strategies to increase influenza vaccine production and surge-capacity before and during an influenza pandemic.
Guidelines for counseling persons infected with human T-lymphotropic virus type I (HTLV-I) and type II (HTLV-II)
Rima F. Khabbaz,Keiji Fukuda,Jonathan E. Kaplan,Cielso Bianco,William A. Blattner,Michael P. Busch,Roger Y. Dodd,Jay S. Epstein,Ronald O. Gilcher,Craig Jackson,Louis M. Katz,Steven Kleinman,Edward L. Murphy,George J. Nemo,Bernard J. Poiesz,Maria Rios,Elaine M. Sloand,Marian T. Sullivan,Alan E. Williams +18 more
TL;DR: Investigational peptide- and recombinant protein-based serologic assays that can more easily differentiate between antibodies to HTLV-I andHTLV-II have been developed and preliminary data suggest that these investigational tests are potentially useful for typing serum samples.